2014 annual financial data
Biodexa Pharmaceuticals 2014 Operating cash flow margin
Direct answer
Operating cash flow margin was -3,474.52%.
Operating income was -7,715,000 USD and net income was -8,822,000 USD.
Operating cash flow was -5,455,000 USD.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 157,000 USD
- Operating income
- -7,715,000 USD
- Net income
- -8,822,000 USD
- Operating cash flow
- -5,455,000 USD